Gotowa bibliografia na temat „THERAPEUTICS ACTION”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „THERAPEUTICS ACTION”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "THERAPEUTICS ACTION"
Lenz, Kiersten D., Katja E. Klosterman, Harshini Mukundan i Jessica Z. Kubicek-Sutherland. "Macrolides: From Toxins to Therapeutics". Toxins 13, nr 5 (12.05.2021): 347. http://dx.doi.org/10.3390/toxins13050347.
Pełny tekst źródłaCattley, Russell C., i Bert R. Radinsky. "Cancer Therapeutics: Understanding the Mechanism of Action". Toxicologic Pathology 32, nr 1_suppl (styczeń 2004): 116–21. http://dx.doi.org/10.1080/01926230490426507.
Pełny tekst źródłaCefalu, William T., i David Ribnicky. "Modulation of Insulin Action by Botanical Therapeutics". Obesity and Weight Management 5, nr 6 (grudzień 2009): 277–81. http://dx.doi.org/10.1089/obe.2009.0604.
Pełny tekst źródłaEidelman, Cristy, Tracy Sandritter i Jennifer Lowry. "Individualized Pediatric Therapeutics Clinic: Action in Practice". Pediatrics 142, nr 1_MeetingAbstract (1.05.2018): 798. http://dx.doi.org/10.1542/peds.142.1ma8.798.
Pełny tekst źródłaCronstein, Bruce N. "Molecular therapeutics. Methotrexate and its mechanism of action". Arthritis & Rheumatism 39, nr 12 (grudzień 1996): 1951–60. http://dx.doi.org/10.1002/art.1780391203.
Pełny tekst źródłaAlves de Souza, Stephanny Miranda, Blanca Hernández-Ledesma i Theo Luiz Ferraz de Souza. "Lunasin as a Promising Plant-Derived Peptide for Cancer Therapy". International Journal of Molecular Sciences 23, nr 17 (23.08.2022): 9548. http://dx.doi.org/10.3390/ijms23179548.
Pełny tekst źródłaChaney, Sarah. "The action of the imagination". History of the Human Sciences 30, nr 2 (kwiecień 2017): 17–33. http://dx.doi.org/10.1177/0952695116687225.
Pełny tekst źródłaJerome, Christopher P., i Rogely Boyce. "Bone Therapeutics: Safety Considerations, Session Summary". Toxicologic Pathology 45, nr 7 (październik 2017): 855–58. http://dx.doi.org/10.1177/0192623317737231.
Pełny tekst źródłaKordus, Shannon L., Audrey K. Thomas i D. Borden Lacy. "Clostridioides difficile toxins: mechanisms of action and antitoxin therapeutics". Nature Reviews Microbiology 20, nr 5 (26.11.2021): 285–98. http://dx.doi.org/10.1038/s41579-021-00660-2.
Pełny tekst źródłaGuo, Haitao, Justin B. Callaway i Jenny P.-Y. Ting. "Inflammasomes: mechanism of action, role in disease, and therapeutics". Nature Medicine 21, nr 7 (29.06.2015): 677–87. http://dx.doi.org/10.1038/nm.3893.
Pełny tekst źródłaRozprawy doktorskie na temat "THERAPEUTICS ACTION"
Crowley, John J. "Enabling carers to administer depot injections : an action research study". Thesis, University of Greenwich, 2014. http://gala.gre.ac.uk/11617/.
Pełny tekst źródłaRomero-Canelón, Isolda. "Design and mechanism of action of organometallic anticancer complexes". Thesis, University of Warwick, 2012. http://wrap.warwick.ac.uk/55211/.
Pełny tekst źródłaVieira, Goncalves Leonam. "Mechanisms of virucidal action of alcohol and metallic ions against nonenveloped viruses". Thesis, Cardiff University, 2018. http://orca.cf.ac.uk/111705/.
Pełny tekst źródłaCrisford, Anna. "An investigaton into mode of action and selective toxicity of the novel antiparasitic emodepside". Thesis, University of Southampton, 2011. https://eprints.soton.ac.uk/338971/.
Pełny tekst źródłaCooper, David L., Derek E. Murrell, David Roane i Sam Harirforoosh. "Effects of Formulation Design on Niacin Therapeutics: Mechanism of Action, Metabolism, and Drug Delivery". Digital Commons @ East Tennessee State University, 2015. https://dc.etsu.edu/etsu-works/7166.
Pełny tekst źródłaUllah, Imran. "A novel in vitro bioluminescence rate-of-kill (BRoK) assay to study the pharmacodynamic properties of antimalarial drug action in Plasmodium falciparum". Thesis, Keele University, 2016. http://eprints.keele.ac.uk/2411/.
Pełny tekst źródłaWortley, Michael. "An investigation into the efficacy and mechanisms of action of novel therapeutics for chronic cough". Thesis, Imperial College London, 2013. http://hdl.handle.net/10044/1/29125.
Pełny tekst źródłaSayce, Andrew Cameron. "Iminosugars as dengue virus therapeutics : molecular mechanisms of action of a drug entering clinical trials". Thesis, University of Oxford, 2014. http://ora.ox.ac.uk/objects/uuid:8d4da0ce-bfa6-447d-a280-630479f898af.
Pełny tekst źródłaAl, Matrood W. A. A. "Factors that enhance the ability of Pseudomonas aeruginosa to resist the action of antibiotics". Thesis, Liverpool John Moores University, 2016. http://researchonline.ljmu.ac.uk/4727/.
Pełny tekst źródłaMubaraki, Murad. "Pharmacometabolomic study of the human malaria parasite, Plasmodium falciparum : new insights into parasite biology and mode of drug action". Thesis, University of Liverpool, 2013. http://livrepository.liverpool.ac.uk/12337/.
Pełny tekst źródłaKsiążki na temat "THERAPEUTICS ACTION"
Group, Diagram, red. The Parent's emergency guide: An action handbook for childhood illnesses and accidents. London: Corgi, 1986.
Znajdź pełny tekst źródłaLee, Scout. Basic terminology for therapeutic recreation and other action therapies. Wyd. 3. Champaign, Ill: Stipes Pub. Co., 1997.
Znajdź pełny tekst źródłaDiagnosis, breast cancer: The best action plan for navigating your journey. Rolling Meadows, IL: Windy City Publishers, 2012.
Znajdź pełny tekst źródła1950-, Morstyn George, Foote MaryAnn i Lieschke Graham J, red. Hematopoietic growth factors in oncology: Basic science and clinical therapeutics. Totowa, N.J: Humana Press, 2004.
Znajdź pełny tekst źródłaE, Lifson Lawrence, red. Understanding therapeutic action: Psychodynamic concepts of cure. Hillsdale, NJ: Analytic Press, 1996.
Znajdź pełny tekst źródłaPelt, Annemarie C. Glucocorticoids: Effects, action mechanisms, and therapeutic uses. Hauppauge, N.Y: Nova Science, 2011.
Znajdź pełny tekst źródłaCatania, Anna, red. Melanocortins: Multiple Actions and Therapeutic Potential. New York, NY: Springer New York, 2010. http://dx.doi.org/10.1007/978-1-4419-6354-3.
Pełny tekst źródłaYounus, Hina, red. Molecular and Therapeutic actions of Thymoquinone. Singapore: Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-10-8800-1.
Pełny tekst źródłaKeppler, D., A. Stiehl, U. Beuers i M. Trauner, red. Bile Acid Biology and Therapeutic Actions. Dordrecht: Springer Netherlands, 2009. http://dx.doi.org/10.1007/978-1-4020-9644-0.
Pełny tekst źródłaCatania, Anna. Melanocortins: Multiple actions and therapeutic potential. New York: Springer Science+Business Media, 2010.
Znajdź pełny tekst źródłaCzęści książek na temat "THERAPEUTICS ACTION"
Yang, Kun, Robert A. DeAngelis, Janet E. Reed, Daniel Ricklin i John D. Lambris. "Complement in Action: An Analysis of Patent Trends from 1976 Through 2011". W Complement Therapeutics, 301–13. New York, NY: Springer US, 2012. http://dx.doi.org/10.1007/978-1-4614-4118-2_21.
Pełny tekst źródłaStrijack, Bradford, i Paul A. Keown. "Cyclosporine: Molecular Action to Clinical Therapeutics". W Immunotherapy in Transplantation, 197–223. Oxford, UK: Wiley-Blackwell, 2012. http://dx.doi.org/10.1002/9781444355628.ch15.
Pełny tekst źródłaZipfel, Peter F., i Nadine Lauer. "Defective Complement Action and Control Defines Disease Pathology for Retinal and Renal Disorders and Provides a Basis for New Therapeutic Approaches". W Complement Therapeutics, 173–87. Boston, MA: Springer US, 2012. http://dx.doi.org/10.1007/978-1-4614-4118-2_11.
Pełny tekst źródłaZhang, Zuo, i Gordon G. Carmichael. "Mechanism of Action of Antisense RNA in Eukaryotic Cells". W Nucleic Acid Therapeutics in Cancer, 89–104. Totowa, NJ: Humana Press, 2004. http://dx.doi.org/10.1007/978-1-59259-777-2_7.
Pełny tekst źródłaTakahama, K., T. Shirasaki i F. Soeda. "Central Mechanisms III: Neuronal Mechanisms of Action of Centrally Acting Antitussives Using Electrophysiological and Neurochemical Study Approaches". W Pharmacology and Therapeutics of Cough, 219–40. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-79842-2_11.
Pełny tekst źródłaRainsford, K. D. "Mechanisms of Inflammation and Sites of Action of NSAIDs". W Ibuprofen: Pharmacology, Therapeutics and Side Effects, 43–57. Basel: Springer Basel, 2012. http://dx.doi.org/10.1007/978-3-0348-0496-7_3.
Pełny tekst źródłaPrabhakar, Pranav Kumar, Yachana Mishra i Vijay Mishra. "Potential Preventive and Therapeutic Accountability of Probiotics in Cancer: An Insight of Mechanism of Action". W Probiotic Research in Therapeutics, 29–45. Singapore: Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-8214-1_2.
Pełny tekst źródłaHsu, Jennifer L., i Mien-Chie Hung. "Mechanisms of Action and Resistance of Trastuzumab in Breast Cancer". W Resistance to Targeted Anti-Cancer Therapeutics, 51–66. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-67932-7_3.
Pełny tekst źródłaArechavala-Gomeza, Virginia, i Alejandro Garanto. "Antisense RNA Therapeutics: A Brief Overview". W Methods in Molecular Biology, 33–49. New York, NY: Springer US, 2022. http://dx.doi.org/10.1007/978-1-0716-2010-6_2.
Pełny tekst źródłaSchmitt, Sara M., Rahul R. Deshmukh i Q. Ping Dou. "Proteasome Inhibitors and Lessons Learned from Their Mechanisms of Action and Resistance in Human Cancer". W Resistance to Targeted Anti-Cancer Therapeutics, 1–46. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-06752-0_1.
Pełny tekst źródłaStreszczenia konferencji na temat "THERAPEUTICS ACTION"
Papineni, Rao, i Amithava Adhikary. "Abstract 482: Multiple chemical action cancer therapeutics". W Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.am2020-482.
Pełny tekst źródłaBakay, Emel, Hilal Er, Aysenur Pamukcu, Didem Sen Karaman i Nermin Topaloglu. "Enhanced photodynamic action with chlorin e6 and indocyanine green incorporated mesoporous silica nanoparticles against prostate cancer cells". W Translational Biophotonics: Diagnostics and Therapeutics, redaktorzy Lothar D. Lilge i Zhiwei Huang. SPIE, 2021. http://dx.doi.org/10.1117/12.2615066.
Pełny tekst źródłaPei, Yi, Thomas Pohl, Ahmed Hassan, Anna Przybyla, Raymond Yu, Huarui Lu, Fangqiang Tang i in. "Abstract 920: Harnessing multiple mechanisms of action to target Nectin-4 as anti-tumor therapeutics". W Proceedings: AACR Annual Meeting 2021; April 10-15, 2021 and May 17-21, 2021; Philadelphia, PA. American Association for Cancer Research, 2021. http://dx.doi.org/10.1158/1538-7445.am2021-920.
Pełny tekst źródłaGiandomenico, Silvana Di, Roberta Frapolli, Ezia Bello, Silvana Pilotti, Paolo Casali, Federica Grosso, Roberta Sanfilippo, Alessandro Gronchi, Carlos Galmarini i Maurizio D'Incalci. "Abstract A17: Mode of action of trabectedin in myxoid liposarcomas." W Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Nov 12-16, 2011; San Francisco, CA. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1535-7163.targ-11-a17.
Pełny tekst źródłaPandiella, Atanasio, Juan Carlos Montero, Lolin Cuenca-Lopez, Florencia Re-Louhau, Francisco Moris i Alberto Ocana. "Abstract B39: Action of EC8042 in triple-negative breast cancer." W Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Nov 12-16, 2011; San Francisco, CA. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1535-7163.targ-11-b39.
Pełny tekst źródłavan der Kraan, A. Gabrielle J., Ryan R. Chai, Michelle M. Kouspou, Ben J. Lang, Preetinder P. Singh, Jiake Xu, Damien Eeles, Matthew T. Gillespie, Julian M. Quinn i John T. Price. "Abstract 2933: HSP90 inhibiting anti-cancer therapeutics enhance bone loss by increasing osteoclast formation: Mechanism of action." W Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-2933.
Pełny tekst źródłaMatthews, Charles S., Andrew J. McCarroll, Malcolm FG Stevens, Anne Monks i Tracey D. Bradshaw. "Abstract B164: Role of endoplasmic reticulum stress in mechanism of action of antitumor quinols". W Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Nov 15-19, 2009; Boston, MA. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/1535-7163.targ-09-b164.
Pełny tekst źródłaMartínez-Diez, Marta, Juan Fernando Martínez-Leal, Luis F. Garcia-Fernandez i Carlos M. Galmarini. "Abstract A177: Mode of action of PM060184, a new interfacial microtubule inhibitor of marine origin." W Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Oct 19-23, 2013; Boston, MA. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1535-7163.targ-13-a177.
Pełny tekst źródłaFerreira, Germano A., Carolina H. Thome, Guilherme A. dos Santos, Priscila S. Scheucher, Andreia M. Leopoldino, Ana M. Simão, Clarice Izume i in. "Abstract A229: Mechanism of action of perifosine on the mantle cell lymphoma line, Granta-519." W Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Oct 19-23, 2013; Boston, MA. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1535-7163.targ-13-a229.
Pełny tekst źródłaSmaill, Jeff B., Jagdish Jaiswal, Maria Abbattista, Guo-Liang Lu, Robert F. Anderson, Amir Ashoorzadeh, William A. Denny i in. "Abstract A247: Mechanism of action of the hypoxia-activated irreversible pan-HER inhibitor SN29966." W Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Nov 12-16, 2011; San Francisco, CA. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1535-7163.targ-11-a247.
Pełny tekst źródłaRaporty organizacyjne na temat "THERAPEUTICS ACTION"
Arnold, Jonathon, David Allsop, Nicholas Lintzeris i Iain McGregor. Pharmacological actions and associated therapeutic levels of phytocannabinoids Addendum 2021. The Sax Institute, styczeń 2016. http://dx.doi.org/10.57022/ovds2305.
Pełny tekst źródłaCabot, Myles C. A Dual-Action Approach to Multidrug-Resistant Breast Cancer: Prophylaxis to Ensure Therapeutic Effect. Fort Belvoir, VA: Defense Technical Information Center, luty 2007. http://dx.doi.org/10.21236/ada469157.
Pełny tekst źródłaDavidson, Nancy E. Therapeutic and Chemopreventive Actions of a Novel Polywmine Analog Against Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, wrzesień 2001. http://dx.doi.org/10.21236/ada397040.
Pełny tekst źródłaDavidson, Nancy E. Therapeutic and Chemopreventive Actions of a Novel Polyamine Analog Against Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, wrzesień 2002. http://dx.doi.org/10.21236/ada409999.
Pełny tekst źródłaDavidson, Nancy E. Therapeutic and Chemopreventive Actions of a Novel Polyamine Analog Against Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, wrzesień 2003. http://dx.doi.org/10.21236/ada420346.
Pełny tekst źródłaDavidson, Nancy E. Therapeutic and Chemopreventive Actions of a Novel Polyamine Analog Against Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, wrzesień 2000. http://dx.doi.org/10.21236/ada391732.
Pełny tekst źródłaElmann, Anat, Orly Lazarov, Joel Kashman i Rivka Ofir. therapeutic potential of a desert plant and its active compounds for Alzheimer's Disease. United States Department of Agriculture, marzec 2015. http://dx.doi.org/10.32747/2015.7597913.bard.
Pełny tekst źródłaVishwanath, Arundathi. Theatre and Art in Education for Young Women with a Focus on Theatre of the Oppressed Techniques and Embodied Therapeutic Practices. Indian Institute for Human Settlements, 2023. http://dx.doi.org/10.24943/tesf0105.2023.
Pełny tekst źródłaShijani, Seyed Mohammad Malakooti, Sina Neshat, Hossein Shayestehyekta i Milad Gorgani. Lance-Adams syndrome; what we know now. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, listopad 2022. http://dx.doi.org/10.37766/inplasy2022.11.0025.
Pełny tekst źródłaBrown, George B. Development and Testing of an In Vitro Assay for Screening of Potential Therapeutic Agents Active against Na Channel Neurotoxins. Fort Belvoir, VA: Defense Technical Information Center, kwiecień 1991. http://dx.doi.org/10.21236/ada237159.
Pełny tekst źródła